Drug intelligence / Profile preview

TLX593-Px

Development stage
Unknown
Lead developer
Telix Pharmaceuticals
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Administration
Intravenous
01

Overview

TLX593-Px is a novel radiopharmaceutical PET imaging agent designed to target Prostate-Specific Membrane Antigen (PSMA). It is developed using the AlFluor platform, which utilizes an aluminum-fluoride (AlF) chemistry to enable the rapid, one-step radiolabeling of molecules with Fluorine-18 (18F). This approach combines the high-resolution imaging characteristics of 18F with the specificity of PSMA-targeting ligands. The agent was acquired by Telix Pharmaceuticals through a strategic agreement with University Hospital Ghent and Ghent University, which provided Telix with a comprehensive CMC package and clinical data from a Phase 3 trial. TLX593-Px is primarily intended for the detection, staging, and monitoring of prostate cancer.

02

Targets

CA9 (Carbonic anhydrase IX)PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on TLX593-Px.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLX593-Px.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call